Geodon Withdrawal & Tapering Guide
ziprasidone
Boxed Warning
Increased mortality in elderly patients with dementia-related psychosis.
In short
Geodon (ziprasidone) is an Atypical Antipsychotic with a half-life of ~7 hours. Slow taper, with food. Withdrawal symptoms, when they occur, usually begin 2-5 days and settle within 2-4 weeks. It is also sold as Zeldox.
- Class
- Atypical Antipsychotic
- Half-life
- ~7 hours
- Common doses
- 20mg, 40mg, 60mg, 80mg capsules; 20mg/mL injection (IM)
- Withdrawal onset
- 2-5 days
- Typical resolution
- 2-4 weeks
Educational reference only. Dose changes are decided with the prescriber who knows your history.
Overview
Ziprasidone is an atypical antipsychotic for schizophrenia and acute mania. Lower metabolic burden than most atypicals but among the highest QT-prolongation risks in the class. Must be taken with food (≥500 calories) for proper absorption.
20mg, 40mg, 60mg, 80mg capsules; 20mg/mL injection (IM)
Capsules: 20mg, 40mg, 60mg, 80mg; IM injection: 20mg/mL
Category C
Mechanism of Action
D2 antagonist; potent 5-HT2A antagonist; some serotonin-norepinephrine reuptake inhibition; 5-HT1A partial agonism.
Taper Notes
Slow taper, with food. ECG check if cardiac history.
Hyperbolic Tapering Guidance
Lower metabolic burden than olanzapine/quetiapine but distinctive cardiac considerations. Tardive risk applies to all dopamine antagonists.
Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.
Withdrawal Timeline
2-5 days
1-2 weeks
2-4 weeks
Tardive symptoms can emerge weeks-to-months after taper
Common Withdrawal Symptoms
Interactions & Safety
Drug Interactions
- Other QT-prolonging drugs — contraindicated
- CNS depressants — additive sedation
Contraindications
- QT prolongation, recent MI, uncompensated heart failure
- Concurrent QT-prolonging medications
Toxicity
QT prolongation (highest among atypicals), sedation, akathisia, EPS, NMS, rash (Stevens-Johnson rare), tardive dyskinesia.
Pharmacokinetics
ADME Profile
Hepatic via aldehyde oxidase (major) and CYP3A4 (minor).
>99%
Need a clinician who understands tapering?
Browse our map of deprescribing-informed providers worldwide.
Other Drug Profiles
The arithmetic of a proportional reduction
The Maudsley Deprescribing Guidelines and NICE NG222 describe reducing Atypical Antipsychotic medications by a proportion of the previous dose rather than by a fixed amount, so each cut is smaller than the last. The table shows what that arithmetic produces at 10% per step, using 40 mg only as a worked example. How large each step is, how long it is held, and whether this pattern applies at all are decisions for the person and their prescriber.
| Step | % of starting dose | Worked example (40 mg start) |
|---|---|---|
| Start | 100% | 40 mg |
| Step 1 | 90% | 36 mg |
| Step 2 | 81% | 32.4 mg |
| Step 3 | 73% | 29.2 mg |
| Step 4 | 66% | 26.2 mg |
| Step 5 | 59% | 23.6 mg |
| Step 6 | 53% | 21.3 mg |
| Step 7 | 48% | 19.1 mg |
| Step 8 | 43% | 17.2 mg |
This is an illustration of a published method, not a schedule for anyone. It does not account for how long you have taken Geodon, your current dose, formulation, or history. TaperCommunity does not recommend doses or dose changes; those are agreed with your prescriber.
Frequently asked questions about Geodon
What are the withdrawal symptoms of Geodon (ziprasidone)?
Common withdrawal symptoms of Geodon (ziprasidone) include: rebound psychosis, rebound insomnia, akathisia, anxiety. Symptom severity varies by individual, dose, and duration of use.
How should I taper off Geodon (ziprasidone)?
Slow taper, with food. ECG check if cardiac history. Lower metabolic burden than olanzapine/quetiapine but distinctive cardiac considerations. Tardive risk applies to all dopamine antagonists.
How long does Geodon withdrawal last?
Geodon withdrawal typically begins 2-5 days, peaks around 1-2 weeks, and resolves within 2-4 weeks. Tardive symptoms can emerge weeks-to-months after taper
Can I stop Geodon cold turkey?
Stopping Geodon abruptly is not recommended. Its half-life is ~7 hours, and the receptor adaptations built up during treatment do not reverse at that speed, so a sudden stop tends to produce the sharpest withdrawal. Prescribing guidance favours gradual, proportional reductions agreed with your prescriber.
How long does Geodon stay in your system?
Geodon (ziprasidone) has a half-life of ~7 hours. A drug is mostly cleared after about five half-lives, so Geodon is largely out of the body about 35 hours after the last dose, longer in older adults or with liver or kidney impairment. Withdrawal symptoms often begin before the drug has fully cleared and continue after it has, because the adaptations the brain made during treatment reverse more slowly than the drug leaves the blood.
Sources & References
Geodon (ziprasidone) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.
Encyclopedic & chemical databases
Neutral, high-authority entity references.
Regulatory sources
Official prescribing information and safety notices.
Peer-reviewed research
Primary literature cited in this taper guide.
- Horowitz MA, Jauhar S, Natesan S, Murray RM, Taylor D 2021 — A method for tapering antipsychotic treatment that may minimize the risk of relapse (Schizophrenia Bulletin)
- Tranter R, Healy D 1998 — Antipsychotic withdrawal symptoms: phenomenology and pathophysiology (Journal of Psychopharmacology)
- Davies J, Read J 2019 — A systematic review into the incidence, severity and duration of antidepressant withdrawal effects (Addictive Behaviors)
Clinical guidelines
Evidence-based deprescribing and prescribing standards.
Deprescribing-specific resources
Clinician-facing references on tapering protocols.
- Royal College of Psychiatrists — Antipsychotics — UK clinical guidance on antipsychotic prescribing and discontinuation
- Council for Evidence-Based Psychiatry (CEP UK) — Evidence-based critique of long-term antipsychotic prescribing
- Deprescribing.org — Antipsychotic deprescribing algorithm for insomnia and BPSD
Patient-advocacy & lived-experience
Long-running communities documenting withdrawal experience.
- Surviving Antidepressants — antipsychotic tapering forum — Community archive of antipsychotic taper experiences
- Mad in America — antipsychotic archive — Independent journalism on antipsychotics and withdrawal
- Inner Compass Initiative — Withdrawal Project — Peer-led psychiatric drug withdrawal resources
- RxISK — adverse drug reaction reporting — Independent database of antipsychotic adverse-effect reports
TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.